Hiscox Stock - weekly review and insurance sector comparison

Hiscox stock closes a muted week on the London market, with the specialty insurer still trading as part of the FTSE 250. The focus for investors now is on how the group is positioned versus UK-listed insurance peers after a strong 2023.

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 13:29 CET. Details in the imprint.

Hiscox (BMG4593F1389) remains a mid-cap insurance name on the London Stock Exchange as part of the FTSE 250 index. With no fresh company news this week, attention turns to how the insurer’s stock has fared over the past days compared with its sector peers.

How Hiscox stock ended the week

Hiscox shares trade in London under the ticker HSX and are part of the FTSE 250, giving the insurer exposure to a broad mid-cap investor base. According to the London Stock Exchange, the group remains firmly categorized within the non-life insurance segment.

Market data providers describe recent trading in the stock as relatively muted, with no outsized price swings or unusual volumes reported over the last few sessions. Against this backdrop, performance is increasingly assessed in relation to peers in the UK insurance sector rather than on standalone headlines this week.

Weekly review and sector comparison

Hiscox is frequently compared with names such as Beazley and Lancashire in the London-listed specialty and reinsurance space, as well as broader composite insurers like Aviva. All operate in segments benefiting from a multi-year “hard market” in commercial and specialty lines, with higher premium rates supporting earnings.

Analyst commentary compiled by independent platforms continues to describe sentiment on Hiscox as cautiously optimistic, reflecting resilience after past reserve challenges and pandemic-related claims. According to this research, several large banks, including Jefferies and Barclays, maintain Buy or Hold stances following the strong 2023 full-year results.

What recent earnings showed

In its last published annual report, Hiscox highlighted solid premium growth and improved underwriting profitability across key lines. Management pointed to disciplined risk selection and favorable pricing conditions, especially in London Market and reinsurance business, as drivers of the improved combined ratio.

For retail and small commercial customers, Hiscox reported continued expansion in digital distribution and partnerships, which support scale without fully matching the volatility of large-ticket specialty risks. This setup allows the group to balance growth opportunities with the need to protect capital in more cyclical reinsurance segments.

The product behind the stock

Hiscox makes its money primarily from specialty insurance and reinsurance, including professional indemnity, cyber cover, property and catastrophe lines. The company also writes policies for small businesses and affluent individuals, offering tailored products like fine art insurance and high-value home coverage.

Where the stock trades today

Hiscox shares (BMG4593F1389) trade on the London Stock Exchange at GBP 11.40 as of 06/19/2026, 12:30 BST.

Key facts on Hiscox stock

• Company: Hiscox Ltd
• ISIN: BMG4593F1389
• WKN: A0CAQ6
• Ticker: HSX
• Venue: London Stock Exchange
• Price (as of 06/19/2026, 12:30 BST): 11.40 GBP
• Market cap: 4,000,000,000 GBP (as of 06/19/2026)
• Sector / Industry: Financials / Non-life insurance
• Index membership: FTSE 250
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.